Applied Health Economics and Health Policy

2008 - 2025

Current editor(s): Timothy Wrightson

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 13, issue 6, 2015

Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY pp. 557-565

John Brazier and Aki Tsuchiya

Estimating the Costs of Torture: Challenges and Opportunities pp. 567-581

Emmanuel Mpinga, Ngianga-Bakwin Kandala, Jennifer Hasselgård-Rowe, Félicien Tshimungu Kandolo, Henk Verloo, Ngoyi Bukonda and Philippe Chastonay

The Debrisoft ® Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance pp. 583-594

Catherine Meads, Eleonora Lovato and Louise Longworth

A Systematic Review of the State of Economic Evaluation for Health Care in India pp. 595-613

Shankar Prinja, Akashdeep Chauhan, Blake Angell, Indrani Gupta and Stephen Jan

The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review pp. 615-626

Stuart Wright, Cheryl Jones, Katherine Payne, Nimarta Dharni and Fiona Ulph

Hospital Utilization and Universal Health Insurance Coverage: Evidence from the Massachusetts Health Care Reform Act pp. 627-635

Attila Cseh, Brandon Koford and Ryan Phelps

Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden pp. 637-645

Madlaina Costa-Scharplatz, Björn Ställberg, Pankaj Goyal, Yumi Asukai, Jean-Bernard Gruenberger and David Price

Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study pp. 647-659

Renee Lévesque, Daniele Marcelli, Héloïse Cardinal, Marie-Line Caron, Muriel Grooteman, Michiel Bots, Peter Blankestijn, Menso Nubé, Aileen Grassmann, Bernard Canaud and Afschin Gandjour

Volume 13, issue 5, 2015

Medicare’s Mission to Change How Health Care is Paid for and Delivered: A Cloud with a Silver Lining or Just a Dark Cloud? pp. 433-435

Jeffrey Voigt

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement pp. 437-443

Stavros Petrou, Oliver Rivero-Arias, Helen Dakin, Louise Longworth, Mark Oppe, Robert Froud and Alastair Gray

Vision Amniotic Leak Detector (ALD) to Eliminate Amniotic Fluid Leakage as a Cause of Vaginal Wetness in Pregnancy: A NICE Medical Technology Guidance pp. 445-456

A. Ray, S. Peirce, A. Wilkes and G. Carolan-Rees

A Systematic Review of Economic Evaluations of the Use of Robotic Assisted Laparoscopy in Surgery Compared with Open or Laparoscopic Surgery pp. 457-467

Zafer Tandogdu, Luke Vale, Cynthia Fraser and Craig Ramsay

A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis pp. 469-483

Barbara Graaff, Amanda Neil, Kristy Sanderson, Lei Si, Kwang Yee and Andrew Palmer

Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study pp. 485-492

Julie Ratcliffe, Gang Chen, Katherine Stevens, Sandra Bradley, Leah Couzner, John Brazier, Michael Sawyer, Rachel Roberts, Elisabeth Huynh and Terry Flynn

A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda pp. 493-506

Solomon Lubinga, Byamah Mutamba, Angelo Nganizi and Joseph Babigumira

The Robustness and Effectiveness of the Triage System at Times of Overcrowding and the Extra Costs due to Inappropriate Use of Emergency Departments pp. 507-514

Paolo Cremonesi, Enrico Bella, Marcello Montefiori and Luca Persico

An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in Cyprus pp. 515-523

Panagiotis Petrou

Cost-Effectiveness of School-Based Prevention of Cannabis Use pp. 525-542

Charlotte Deogan, Natalie Zarabi, Nils Stenström, Pi Högberg, Eva Skärstrand, Edison Manrique-Garcia, Kristian Neovius and Anna Månsdotter

Implementing Guidelines: The Cost and Clinical Impact of Anticoagulants in the UK Atrial Fibrillation Population pp. 543-551

Gemma Shields, Alexander Bates and Ann-Marie Chapman

Volume 13, issue 4, 2015

The Value of Productivity in Health Policy pp. 311-313

Wilbert Van den Hout

VibraTip™ for Testing Vibration Perception to Detect Diabetic Peripheral Neuropathy: A NICE Medical Technology Guidance pp. 315-324

Iain Willits, Helen Cole, Roseanne Jones, Paul Dimmock, Mick Arber, Joyce Craig and Andrew Sims

A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection pp. 325-340

Jonathon Campbell, Thenuga Sasitharan and Fawziah Marra

US and International In-Hospital Costs of Extracorporeal Membrane Oxygenation: a Systematic Review pp. 341-357

Michael Harvey, Michael Gaies and Lisa Prosser

Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches pp. 359-367

Alison Pearce, Paul Hanly, Aileen Timmons, Paul Walsh, Ciaran O’Neill, Eleanor O’Sullivan, Rachael Gooberman-Hill, Audrey Thomas, Pamela Gallagher and Linda Sharp

Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis pp. 369-379

Santiago Grau, Virginia Lozano, Amparo Valladares, Rafael Cavanillas, Yang Xie and Gonzalo Nocea

The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011 pp. 381-387

Kenneth Thorpe, Lindsay Allen and Peter Joski

Equitable Prices of Single-Source Drugs in Thailand pp. 389-397

Surachat Ngorsuraches and Kanokkan Chaiyakan

Health Economic Evaluation of a Strict Glucose Control Guideline Implemented Using Point-of-Care Testing in Three Intensive Care Units in The Netherlands pp. 399-407

Roosmarijn Hooijdonk, Lotte Steuten, Michelle Kip, Helma Monteban, Marianne Mulder, Floris Braam Houckgeest, Johannes Sluijs, Ameen Abu-Hanna, Peter Spronk and Marcus Schultz

A Comparison of Japan and UK SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method pp. 409-420

Samer Kharroubi

Cost Effectiveness of Using Array-CGH for Diagnosing Learning Disability pp. 421-432

G. Sagoo, S. Mohammed, G. Barton, G. Norbury, J. Ahn, C. Ogilvie and M. Kroese

Volume 13, issue 3, 2015

An Economist’s Influence on Health Policy pp. 265-267

Peter Zweifel

Cost-Effectiveness Analysis: A View into the Abyss pp. 269-271

Paul Kind

How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States? pp. 273-279

Don Husereau, Anthony Culyer, Peter Neumann and Philip Jacobs

Health Economics and Health Policy: Experiences from New Zealand pp. 281-289

Jacqueline Cumming

Health Technology Assessment of Cancer Drugs in Canada, the United Kingdom and Australia: Should the United States Take Notice? pp. 291-302

George Dranitsaris and George Papadopoulos

Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake pp. 303-309

Gregory Merlo, Katie Page, Julie Ratcliffe, Kate Halton and Nicholas Graves

Volume 13, issue 2, 2015

The Case of Penny Wise but Access and Quality of Care Foolish pp. 121-123

Jeffrey Voigt

Biosimilar Versus Generic Drugs: Same But Different? pp. 125-127

Katelijne Vooren, Alessandro Curto and Livio Garattini

Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems pp. 129-133

Fred Hellinger

The geko™ Electro-Stimulation Device for Venous Thromboembolism Prophylaxis: A NICE Medical Technology Guidance pp. 135-147

Jennifer Summers, James Clinch, Muralikrishnan Radhakrishnan, Andy Healy, Viktoria McMillan, Elizabeth Morris, Tiago Rua, Mercy Ofuya, Yanzhong Wang, Paul Dimmock, Cornelius Lewis, Janet Peacock and Stephen Keevil

A Systematic Review on Cost Effectiveness of HIV Prevention Interventions in the United States pp. 149-156

Ya-Lin Huang, Arielle Lasry, Angela Hutchinson and Stephanie Sansom

Funding, Coverage, and Access Under Thailand’s Universal Health Insurance Program: An Update After Ten Years pp. 157-166

Kannika Damrongplasit and Glenn Melnick

Cost-Effectiveness and Value of Information Analysis of Nutritional Support for Preventing Pressure Ulcers in High-risk Patients: Implement Now, Research Later pp. 167-179

Haitham Tuffaha, Shelley Roberts, Wendy Chaboyer, Louisa Gordon and Paul Scuffham

Opioid Misuse Among Adolescents: New Evidence from a Misclassification Analysis pp. 181-192

Sean Murphy, Daniel Friesner and Robert Rosenman

Potential Savings in Prescription Drug Costs for Hypertension, Hyperlipidemia, and Diabetes Mellitus by Equivalent Drug Substitution in Austria: A Nationwide Cohort Study pp. 193-205

Georg Heinze, Milan Hronsky, Berthold Reichardt, Christoph Baumgärtel, Marcus Müllner, Anna Bucsics and Wolfgang Winkelmayer

The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010 pp. 207-222

Frank Lichtenberg

An Estimation of the Value of Informal Care Provided to Dependent People in Spain pp. 223-231

Juan Oliva, Luz Peña-Longobardo and Cristina Vilaplana-Prieto

Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism pp. 233-242

C. Rubio-Terrés, J. Soria, P. Morange, J. Souto, P. Suchon, J. Mateo, N. Saut, D. Rubio-Rodríguez, J. Sala, A. Gracia, S. Pich and E. Salas

A Prediction Model of Childhood Immunization Rates pp. 243-251

Elizabeth Crouch and Lori Dickes

Prospective Randomized Controlled Trial Comparing the Outcomes and Costs of Two Eyecare Adherence Interventions in Diabetes Patients pp. 253-263

Laura Pizzi, Camila Zangalli, Ann Murchison, Nicole Hale, Lisa Hark, Yang Dai, Benjamin Leiby and Julia Haller

Volume 13, issue 1, 2015

Systematic Overuse of Healthcare Services: A Conceptual Model pp. 1-6

Najlla Nassery, Jodi Segal, Eva Chang and John Bridges

Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests? pp. 3-4

Livio Garattini and Katelijne Vooren

Definition and Classification of Generic Drugs Across the World pp. 5-11

Rafael Alfonso-Cristancho, Tatiana Andia, Tatiana Barbosa and Jonathan Watanabe

Kinky Thresholds Revisited: Opportunity Costs Differ in the NE and SW Quadrants pp. 7-13

Simon Eckermann

A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators pp. 13-20

Shanlian Hu, Yabing Zhang, Jiangjiang He, Lixia Du, Mingfei Xu, Chunyan Xie, Ying Peng and Linan Wang

A Review of the Economic Tools for Assessing New Medical Devices pp. 15-27

Joyce Craig, Louise Carr, John Hutton, Julie Glanville, Cynthia Iglesias and Andrew Sims

The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review pp. 21-33

H. Gothe, I. Schall, K. Saverno, M. Mitrovic, A. Luzak, D. Brixner and U. Siebert

Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Medical Management or Surgery for Patients with Aortic Stenosis pp. 29-45

Andrea Iannaccone and Thomas Marwick

A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges? pp. 35-45

Else-Lydia Toverud, Katrin Hartmann and Helle Håkonsen

Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience pp. 47-59

François Bocquet, Pascal Paubel, Isabelle Fusier, Anne-Laure Cordonnier, Martine Sinègre and Claude Le Pen

Direct Costs of Unintended Pregnancy in the Russian Federation pp. 61-68

Julia Lowin, James Jarrett, Maria Dimova, Victoria Ignateva, Vitaly Omelyanovsky and Anna Filonenko

Healthcare Costs Associated with Antiretroviral Adherence Among Medicaid Patients pp. 69-80

Zachary Pruitt, John Robst, Barbara Langland-Orban and Robert Brooks

Comparing Willingness to Pay for Improved Drinking-Water Quality Using Stated Preference Methods in Rural and Urban Kenya pp. 81-94

Roy Brouwer, Fumbi Job, Bianca Kroon and Richard Johnston

Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening pp. 95-107

Warner Huh, Erin Williams, Joice Huang, Tommy Bramley and Nick Poulios

Migraine-Related Healthcare Resource Use and Costs for Subjects Prescribed Fixed-Dose Combination Sumatriptan/Naproxen Sodium vs. Single-Entity Oral Triptans in a Managed Care Population in the USA pp. 109-120

M. Runken, Bridgett Goodwin, Manan Shah, Michael Eaddy, Anna D’Souza, Brian Bowers and Christopher Bell